ONVO – organovo holdings, inc. (US:NASDAQ)
Stock Stats
News
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Organovo's fatty liver disease drug meets main goal in mid-stage study [Reuters]
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Financial Post (Toronto, Ontario, Canada)
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Yahoo! Finance]
Form 8-K ORGANOVO HOLDINGS, INC. For: May 01
Form S-1/A ORGANOVO HOLDINGS, INC.
Form 8-K ORGANOVO HOLDINGS, INC. For: Apr 19
Form S-1 ORGANOVO HOLDINGS, INC.
Form SC 13G/A ORGANOVO HOLDINGS, INC. Filed by: Nikko Asset Management Americas, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.